Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$174,864,912
+$144,170,350 QoQ
Shares Held
145,790
+336.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#284
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 13%
None 13%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,486,971,678 across 12 Drug Manufacturers - General names. LLY ranks #5 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539,098 | $2,676,614,716 | |
| 2 | PFE |
Pfizer Inc
|
56,551,011 | $1,361,748,341 | |
| 3 | ABBV |
AbbVie Inc.
|
4,388,338 | $1,104,281,370 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,651,833 | $840,392,576 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
145,790 | $174,864,912 | |
| 6 | BIIB |
Biogen Inc.
|
744,892 | $160,941,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
948,427 | $54,648,359 | |
| 8 | NVS |
Novartis AG
|
293,443 | $45,988,386 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,864,912 | 145,790 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $30,694,562 | 33,372 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $41,339,716 | 38,467 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $23,076,172 | 30,244 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $170,606,374 | 218,858 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $691,149,566 | 836,834 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $806,908,296 | 1,045,218 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,710,633,192 | 1,930,868 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,321,965,611 | 2,564,631 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,421,851,714 | 3,113,080 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,873,130,058 | 3,213,357 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,778,361,691 | 3,310,859 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,250,012,722 | 2,665,386 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $340,976,219 | 992,884 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $390,939,548 | 1,068,608 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $412,063,009 | 1,274,356 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $448,570,255 | 1,383,494 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $428,122,860 | 1,494,999 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $442,654,699 | 1,602,544 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $437,253,803 | 1,892,464 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $501,453,226 | 2,184,791 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $479,966,171 | 2,569,137 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $567,175,933 | 3,359,251 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $665,812,163 | 4,498,123 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $796,709,879 | 4,852,661 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $706,849,559 | 5,095,513 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||